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Background: Previous research reported that individual differences in the stress response were moderated by an
interaction between individuals’ life stress experience and the serotonin transporter-linked polymorphic region
(5-HTTLPR), a common polymorphism located in the promoter region of the serotonin transporter gene (SLC6A4).
Furthermore, this work suggested that individual differences in SLC6A4 DNA methylation could be one underlying
mechanism by which stressful life events might regulate gene expression. The aim of this study was to understand
the relation between early and recent life stress experiences, 5-HTTLPR genotype, and SLC6A4 methylation. In addition,
we aimed to address how these factors influence gene expression and cortisol response to an acute psychosocial
stressor, operationalized as the Trier Social Stress Test (TSST). In a sample of 105 Caucasian males, we collected
early and recent life stress measures and blood samples to determine 5-HTTLPR genotype and SLC6A4 methylation.
Furthermore, 71 of these participants provided blood and saliva samples before and after the TSST to measure
changes in SLC6A4 and NR3C1 gene expression and cortisol response.
Results: Compared to S-group individuals, LL individuals responded with increased SLC6A4 mRNA levels to the TSST
(t(66) = 3.71, P < .001) and also showed increased global methylation as a function of ELS (r (32) = .45, P = .008) and
chronic stress (r (32) = .44, P = .010). Compared to LL individuals, S-group individuals showed reduced SLC6A4 mRNA
levels (r (41) = −.31, P = .042) and increased F3 methylation (r (67) = .30, P = .015) as a function of ELS; as well as
increased F1 methylation as a function of chronic stress and recent depressive symptoms (r = .41, P < .01), which
correlated positively with NR3C1 expression (r (42) = .31, P = .040).
Conclusions: Both early and recent life stress alter DNA methylation as a function of 5-HTTLPR genotype. Some of these
changes are also reflected in gene expression and cortisol response, differentially affecting individuals’ stress response in
a manner that may confer susceptibility or resilience for psychopathology upon experiencing stressful life events.
Keywords: Early life stress, Serotonin transporter, Glucocorticoid receptor, Gene expression, DNA methylation,
Hypothalamic-pituitary-adrenal axis, DepressionBackground
Studies of gene-by-environment interactions (GxE) have
begun to reveal important clues regarding the etiology of
depression. Much of this research enterprise has been
devoted to the serotonin transporter gene (SLC6A4)
and its interaction with stressful life events (SLEs).
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adrenal axis (HPA) stress response [1,2] and has been im-
plicated in various mood disorders such as depression.
The serotonin transporter is responsible for the reuptake
of excess serotonin in the synaptic cleft and is commonly
targeted by a class of antidepressants known as selective
serotonin reuptake inhibitors. A common variant
(polymorphism) located in the promoter region of the
gene (SLC6A4) encoding the transporter, the serotonin
transporter-linked polymorphic region (5-HTTLPR), has
been widely studied with regard to individual differ-
ences in trait neuroticism, anxiety, and depression. Thentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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allele that differ in transcriptional efficiencies, with the S
allele being less active than the L allele [3,4]. In addition
to the 5-HTTLPR, an A/G single nucleotide polymorph-
ism (SNP; rs25531) located within 5-HTTLPR is suggested
to alter the transcriptional efficiency of the L allele, such
that the LG allele is considered functionally similar to the
S allele [5].
A seminal longitudinal gene-by-environment (GxE)
study by Caspi and colleagues reported that the S allele
moderated increased risk for depression associated with
childhood maltreatment [6]. Subsequent work has pro-
duced conflicting results [7-10], which may be due, in
part, to variation across studies in the selection of the
type and timing of stressful life events (SLEs), sample
size, and assessment of depression [10-13]. With regard
to SLEs, some studies have considered early life stress
(ELS) such as childhood maltreatment, whereas others
have focused on recent SLEs. Indeed, it now appears that
the timing of SLEs is a critical variable in revealing an
interaction with 5-HTTLPR genotype: the most recent,
large-scale meta-analysis by Karg et al. [10] specifically
investigated the effect of stressor type and discovered
that 5-HTTLPR strongly moderated the relationship
between depression and ELS, specifically childhood
maltreatment.
Studies investigating the sequelae of ELS at the mo-
lecular level suggest that these effects may be stable and
persist through adulthood, such as alterations in the ex-
pression of SLC6A4 [14-17] but also see [18]. One of
these studies reported an additive effect of ELS and
5-HTTLPR genotype, such that S carriers with ELS
exhibited the lowest level of baseline SLC6A4 expres-
sion [16]. Given known interactions between seroto-
nergic and glucocorticoid systems [19], ELS-mediated
regulation of SLC6A4 and its effect on the glucocorticoid
receptor (NR3C1) could be one mechanism by which
ELS can affect the HPA response. Activity of HPA is reg-
ulated both by negative feedback of cortisol by binding to
NR3C1 and also through the action of neurotransmitters,
such as serotonin, in specific brain regions [20]. Indeed,
one recent study in rats reported that ELS and a poly-
morphism in SLC6A4 leads to altered hippocampal
NR3C1 expression and cortisol release [21], suggesting
that 5-HTTLPR may alter HPA activity through its ef-
fects on NR3C1 regulation.
Recent studies have begun to study GxE interactions
using laboratory-based social stress tasks, such as the
Trier Social Stress Test (TSST) [22]; or derivations of
the TSST. For example, Alexander et al. [23] reported a
significant interaction between SLEs and 5-HTTLPR
genotype in healthy males such that S carriers with a
high number of SLEs exhibited the highest cortisol re-
sponse. Mueller et al. [24] reported the same interactionin young adults (but not in children or older adults) for
SLEs during the first 5 years of life, which was associated
with increased cortisol responses in S-allele carriers but
decreased cortisol responses in homozygous L-allele car-
riers. These studies, along with other neuroimaging
(such as [25]) and behavioral (such as [26]) studies sug-
gest that 5-HTTLPR genotype moderates stress reactiv-
ity and vulnerability to psychopathology in interaction
with environmental variables.
Other work has begun to address the underlying mo-
lecular mechanisms of these GxE interactions, with a
particular focus on epigenetic changes [27]. The first
epigenetic study investigating the impact of ELS was
conducted in rats [28], focusing on DNA methylation,
which involves the addition of a methyl group to a seg-
ment of DNA containing a CpG dinucleotide. DNA
methylation can alter gene expression when it occurs
across long sections of CpG-rich regions (so-called ‘CpG
islands’) but also when it occurs at specific sites, such as
binding sites for specific transcription factors (TF) [29].
Researchers showed that ELS, operationalized as poor
maternal care with low levels of licking and grooming of
pups, was associated with increased DNA methylation at
a particular CpG site in the hippocampal NR3C1, which
was associated with lower gene expression and with
higher HPA activation in response to stress in adulthood
[28]. Subsequent studies provided further evidence for a
similar methylation pattern in the postmortem hippo-
campi of suicide victims exposed to childhood abuse
[30], in the cord blood of infants with depressed mothers
during pregnancy [31], and in the blood of adults ex-
posed to childhood maltreatment [32]. The similarity of
results across the range of species and tissues studied
suggests that DNA methylation in NR3C1 may be a
highly conserved and ubiquitous mechanism by which
life stress may alter gene expression.
Other studies examined DNA methylation in SLC6A4,
focusing on a CpG island in the promoter region of this
gene, spanning an untranslated exon [33]. Several studies
in humans and in non-human primates reported associa-
tions between ELS and DNA methylation across the CpG
island or at specific CpG sites [34-39]. In addition, some
studies reported associations between methylation of the
whole CpG island (or sections of it) and gene expression
[16,37,40], whereas others reported reduced gene expres-
sion as a result of in vitro methylation of certain CpG sites
[41,42]. 5-HTTLPR genotype appears to further differenti-
ate SLC6A4 methylation, as some studies reported in-
creased methylation in S carriers [33,37] and suggested
that methylation of the S allele may exacerbate the impact
of ELS [34] (although some reported the reverse pattern
in relation to unresolved trauma [43]).
One recent study examined the association between
stressful life experiences, SLC6A4 methylation, and
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of the Trier Social Stress Test, TSST [38]. The study was
based on 28 monozygotic twin pairs who were discordant
for childhood bullying victimization [38] and reported
that bullying victimization was associated with increased
SLC6A4 methylation and a blunted cortisol response to
the TSST. The study did not address the putative moder-
ating role of 5-HTTLPR genotype or the effect on
SLC6A4 mRNA gene expression. These questions were
addressed across a set of two other studies. The first
study was conducted in a population sample of 133
healthy young adults and reported an additive effect of
early life stress (in the form of either prenatal stress or
childhood maltreatment) and presence of the 5-HTTLPR
S allele on reducing baseline SLC6A4 mRNA gene ex-
pression [16]. These investigators also examined SLC6A4
methylation and concluded that the observed differences
in mRNA expression were unlikely to be mediated by
methylation within this gene’s CpG island. In a second,
follow-up study with an enlarged sample of 200 healthy
young adults, this group then used the TSST to show that
SLC6A4 methylation moderated the association between
5-HTTLPR genotype and cortisol response to the TSST
such that S carriers with low SLC6A4 methylation
had higher cortisol responses than LL homozygotes
[44]. There were no differences in cortisol response
by 5-HTTLPR genotype in the high SLC6A4 methylation
group. However, authors did not report any associations
between SLC6A4 methylation and life stress.
In light of the fact that no single prior study combined
all of the putative elements of a molecular GxE inter-
action, the aim of the current study was to first investi-
gate the interaction between ELS and 5-HTTLPR on
SLC6A4 methylation and its association with SLC6A4
and NR3C1 expression and cortisol response following
the TSST. In addition, we investigated whether chronic
stress and recent depressive symptoms would be associ-
ated with SLC6A4 methylation, gene expression, and
cortisol response as a function of 5-HTTLPR genotype,
given that several studies reported correlations between
depressive symptoms, antidepressant response, and




Participants were 105 Caucasian males aged 18 to 77
(M = 28.51, SD = 13.82) who were recruited from
Stony Brook University and surrounding communities
through flyers, newspaper, and online advertisements.
Participants were screened by phone for eligibility. All
participants reported no prior diagnosis of psychological
disorders or use of any related medication. Details of
other exclusion criteria are given in Additional file 1.Measures of early life and chronic stress, 5-HTTLPR
genotype, and DNA methylation (see below) were avail-
able from all of these participants. A subset (N = 71) par-
ticipated in the TSST (Mage = 29.79, SDage = 15.24).
Additional data on recent depressive symptoms, gene ex-
pression, and cortisol response to the TSST were avail-
able from these participants. The study was approved by
the Stony Brook University Institutional Review Board,
and participants provided written consents prior to par-
ticipation in the experimental sessions. At the end of
each session, participants were debriefed orally and in
writing and compensated with $100 plus reimbursement
for any public transportation costs.
Experimental sessions
To standardize biological measures under the influence
of diurnal variation, all experimental sessions started
between 12:00 and 14:00 h. Participants were instructed
to refrain from eating, drinking (other than water), and
exercise for at least 1 h before their arrival. The total
procedure, which took about 4 h, included consenting,
completion of questionnaires, the TSST, a life event
interview, and debriefing. Participants also provided
blood samples for genotyping and DNA methylation
analyses, one at the beginning of the session (45 min
before the TSST) and one at the end (105 min after the
TSST). Cortisol levels were assessed using saliva samples
collected at nine different time points throughout the
session.
Assessment of early life stress
Early life stress was assessed with the Childhood Trauma
Questionnaire (CTQ) [47], which is a commonly used
measure of childhood maltreatment consisting of 28
items with subscales of physical, sexual, and emotional
abuse and physical and emotional neglect. Each subscale
consists of five items, plus three items that serve to con-
trol for denial of maltreatment. The items are rated on a
5-point Likert scale (1 to 5), with higher scores indicat-
ing higher levels of maltreatment. Scores are added up
to calculate the CTQ total score, which can range from
25 to 125.
Assessment of chronic stress and recent depressive
symptoms
Chronic stress for the last 3 months was assessed with
the Trier Inventory of Chronic Stress (TICS) [48,49].
TICS is a 12-item self-report measure on the frequency
of behaviors related to chronic stress, such as ‘I worry
that I will not be able to fulfill my tasks’ and ‘I experi-
ence having too much to do.’ Each item is rated from 0
(never) to 4 (very often), and items are added up to cal-
culate the total chronic stress score, which can range
from 0 to 48.
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Beck Depression Inventory II BDI-II [50]; for assessing
recent depressive symptoms. The BDI-II is a 21-item
self-report measure of recent depressive symptoms (last
2 weeks) such as sadness, hopelessness, and self-blame.
Each item is rated on a scale from 0 to 3, and scores can
range from 0 to 63. Higher scores indicate higher de-
pressive symptoms.
Assessment of cortisol levels and stress reactivity
For the assessment of cortisol levels in response to the
TSST, participants’ saliva samples were collected using
salivettes (Sarstedt, Rommelsdorf, Germany). Forty-five
minutes after the first blood draw and just prior to the
beginning of the TSST, participants provided baseline
saliva samples and were then taken to the TSST room.
The TSST was performed as described in Kirschbaum
et al. [22]. Briefly, the task consisted of a preparation
phase (5 min), which was followed by a public speech
(5 min) on why the participant would be the best can-
didate for his or her dream job and a backward-
counting task (5 min). The task took place in front of
a two-person committee that provided no verbal or
non-verbal feedback. The active committee member,
who gave instructions to the subject during the TSST,
was always of the opposite sex (female); the inactive
committee member, who did not communicate with
the participant, was always of the same sex (male) as
the participant. After the TSST, participants returned
to the initial testing room and provided a second sal-
iva sample right after the TSST and filled out an 8-
item Visual Analog Scale (VAS) assessing the their
experience of the TSST, such as finding it stressful,
threatening, or challenging. Additional saliva samples
were collected at 10, 20, 30, 45, 60, 90, and 105 min
after the TSST. The saliva samples were stored at −20°C
immediately after the session until being shipped to
Brandeis University, Boston, for the analysis of cortisol
concentration. Each sample was assayed in duplicates
using a commercially available chemiluminescence im-
munoassay (RE62019) with a sensitivity of 0.16 ng/ml
(IBL International, Toronto, ON, Canada). Inter- and
intra-assay coefficients of variation were less than 7% and
4%, respectively. Cortisol peak increase was assessed
as the difference between the peak cortisol level after
the TSST and the baseline as used in prior studies
[23,24]. For all participants, the highest response after
the TSST was observed within 10 to 20 min after the
TSST. We used peak response, rather than area under
the curve, as a measure of cortisol reactivity, because
the former is potentially more closely associated with
changes in gene expression whereas the latter may be
more closely associated with the overall hormonal
output [51].Processing blood samples
In order to start with a uniform group of cells, periph-
eral blood mononuclear cells (PBMCs) were isolated
from blood immediately after the blood draw, using
Leucosep® tubes (Greiner Bio-One Inc., Monroe, NC,
USA) and Ficoll-Paque (GE Healthcare, Pittsburgh, PA,
USA) separation medium according to manufacturer’s
protocol. The isolated PBMC pellets were stored at −80°C
for subsequent DNA and RNA extraction procedures.
DNA and RNA extractions from PBMC pellets were
carried out by the AllPrep DNA/RNA/Protein Mini kit
(Qiagen, Valencia, CA, USA) according to manufac-
turer’s instructions. Quantity and quality of the DNA
and RNA were assessed through NanoDrop ND-1000
(Thermo Scientific, Wilmington, DE, USA), DNA sam-
ples were stored at −20°C, and RNA samples were stored
at −80°C.
Genotyping of 5-HTTLPR and rs25531
5-HTTLPR genotype was determined through PCR
amplification of 25 ng DNA at an annealing temperature
of 67.5°C using primers employed in previous work [5].
A random subset of 24 samples was processed twice by
a technician blind to the initial results to establish test-
retest reliability, which was 100%. As a result of genotyp-
ing, individuals were genotyped as S/S, S/L, or L/L.
For genotyping the A/G SNP (rs25531), 6 μl of the
5-HTTLPR PCR products were digested with 5 Units
of HpaII restriction enzyme (New England Biolabs,
Ipswich, MA, USA) for 3 h at 37°C. As a result, indi-
viduals were genotyped as S/S, S/LA, S/LG, LA/LA,
LA/LG, and LG/LG. Given that expression of LG allele
was suggested to be similar to the S allele [52], the
triallelic (S, LA, LG) classification scheme grouped S/LG
and LG/LG individuals as ‘S/S’ and LA/LG individuals as
‘L/S’. Genotype distributions were in Hardy-Weinberg
equilibrium according to both biallelic and triallelic clas-
sification schemes (P > .05).
DNA methylation analyses
For the analysis of DNA methylation, 500 ng DNA from
each participant at baseline was bisulfite treated by using
the Epitect Bisulfite kit (Qiagen, CA) according to man-
ufacturer’s instructions and stored at −20°C until used in
methylation analyses. In addition, in all methylation ana-
lyses, 500 ng unmethylated (0%) and fully-methylated
(100%) human DNA samples (Zymo Research, Irvine,
CA, USA) were bisulfite treated along with participants’
samples to be utilized as bisulfite conversion controls.
Global DNA methylation
The methylation of Long Interspersed Nuclear Element-1
(LINE-1) was used as a measure of global methylation both
for investigation of associations with ELS (similar to [39])
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ing gene-specific methylation (similar to [31]). LINE-1
methylation was quantified in duplicates by using the
PyroMark Q96 CpG LINE-1 kit (Qiagen, CA) in a
PyroMark Q96 MD system at the Stony Brook University
Genomics Core Facility according to manufacturer’s
protocol and with the commercial primers provided with
the kit. Details of the procedure are given in Additional
file 1.
SLC6A4 CpG island DNA methylation
Methylation of the CpG island upstream of SLC6A4 was
quantified by the Sequenom Epityper MassArray system
(San Diego, CA, USA). Two sets of primers were de-
signed to amplify the 79 CpG sites in the CpG island in
two amplicons similar to Philibert et al. [40] by using
the Epityper software (Sequenom, CA). With this tech-
nique, methylation of CpG Units is analyzed, which can
consist of one or more adjacent CpG sites. A total of 37
CpG Units were covered by the two amplicons, consist-
ing of 79 CpG sites. All samples were run in triplicates.
After preprocessing, methylation data from 26 CpG
Units in amplicons 1 and 2 were included in all analysis
(Figure 1). Details of the procedure, primer sequences,
and data analysis are given in Additional file 1.
Gene expression analyses
For each participant, two RNA samples were used for
gene expression analyses, one 45 min before the TSST
(baseline), and another 105 min after the TSST (response).
Prior to quantification of gene expression, integrity
of the RNA samples was assessed using the Agilent
2100 BioAnalyzer (Agilent Technologies, Santa Clara,
CA, USA). RNA Integrity Numbers (RINs) of the
samples were high (M = 7.94, SD = 1.32), and RINs of
samples before and after the TSST did not differ signifi-
cantly (P = .853). Afterwards, 1 μg of RNA from each
time point was converted to cDNA using QuantiTect
Reverse Transcription Kit according to the manufac-
turer’s protocol (Qiagen, CA). The cDNA samples were
then diluted five times, and 1 μl of the diluted cDNA was
used for the gene expression analysis of the candidateFigure 1 SLC6A4 CpG island amplicons for DNA methylation analysis. Analy
CpG Units 12 to 15 and 5-HTTLPR is located upstream of the CpG island. As
F1 factor loadings ranged from .35 to .83, F2 factor loadings ranged from .37genes by quantitative PCR (qPCR), using the Qiagen
SYBR Green PCR + UNG kit (Qiagen, CA) and gene-
specific primers designed from the Roche Universal
Probe Library website (http://www.roche-applied-science.
com/sis/rtpcr/upl/ezhome.html). The qPCR reactions were
carried out in triplicates in the Roche 480 LightCycler
system (Roche Applied Science, Indianapolis, IN, USA)
at an annealing temperature of 60°C.
To identify the best reference genes in PBMCs, the ex-
pression of six candidate reference genes was analyzed
from five individuals’ RNA samples, obtained at baseline
and response time points. This method identified HPRT1
(hypoxanthine phosphoribosyltransferase 1) and GAPDH
(glyceraldehyde 3-phosphate dehydrogenase) as the best
reference genes in PBMCs. CT values that were obtained
by qPCR were then used to assess gene expression
change between baseline and response samples, using
the delta-delta-CT method [53]. Changes in gene expres-
sion for each sample, normalized for reference genes,
are shown as fold-change values, representing the fold
change in SLC6A4 and NR3C1 after the TSST relative to
baseline. Details of the qPCR analyses and primer se-
quences are given in Additional file 1.
Statistical analysis
All statistical analyses were performed using SPSS for
Windows version 16.0 (Chicago, IL, USA), with signifi-
cance level set at α = .05. In order to assess whether the
TSST successfully evoked a cortisol response, we used a
repeated measures ANOVA for the nine saliva samples
collected throughout the experiment. Prior to all ana-
lyses, cortisol data were tested for normal distribution
by the Kolmogorov-Smirnov test. Due to violation of
normality for samples at multiple time points (P < .05),
log transformation was applied to all cortisol data. Due
to the violation of sphericity (P < .05), Greenhouse-
Geisser correction was applied.
To examine correlations between variables of interest,
Pearson’s correlation coefficient (r) was used for the nor-
mally distributed variables, and Spearman’s rho coeffi-
cient (rs) was used for the non-normally distributed
variables. Partial correlations were used as necessary tozed CpG Units are numbered from 1 to 26. The untranslated exon spans
terisks show the CpG Units belonging to Factors 1, 2, and 3 (F1 to F3).
to .76, and F3 factor loadings ranged from .73 to .87.
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LINE-1 methylation.
In order to understand the methylation patterns across
the CpG island and reduce the number of variables in-
vestigated, a factor analysis covering the 26 CpG Units
across the island was conducted similar to Olsson et al.
[41]. Kaiser-Meyer-Olkin measure of sampling adequacy
(.834) and Bartlett’s test of sphericity (P < .001) sug-
gested that factor analysis is suitable for the data set. As
a result of the analysis, five factors emerged explaining
75% of the variance. However, since fewer than three
variables were loaded onto the last two factors, only the
first three factors were considered: Factor 1 (F1), Factor
2 (F2), and Factor 3 (F3). Percentage of the variance ex-
plained by F1, F2, and F3 were 37, 15, and 12, respect-
ively. Loadings on these factors were such that F1
primarily included CpG Units at the beginning of the
CpG island up to the start of the exon, whereas F2 in-
cluded those towards the end of the island and F3 in-
cluded a shorter region towards the end of the island
(Figure 1).
Results
Participant characteristics and response to the TSST
The study included 105 Caucasian males aged 18 to
77 (Mage = 28.51, SDage = 13.82). The distribution of
5-HTTLPR genotype groups is shown in Table 1.
Furthermore, age did not vary as a function of 5-HTTLPR
genotype (t(103) = 1.19, P = .238; S group M = 27.39,
SD = 13.12; LL group M = 30.77, SD = 15.07). ELS, as
measured by CTQ total scores, ranged from 25 to 66
(M = 34.83, SD = 9.57). Only two participants reported
past sexual abuse (scoring 7 within a range of 5 to 25).
Apart from sexual abuse, all CTQ subscale scores
were significantly correlated with each other (r = .31
to .63) and with the CTQ total score (r = .67 to .86;
P values ≤.001; individual correlation coefficients are
reported in Additional file 1: Table S1). Chronic stress for
the last 3 months, as measured by TICS total scores,
ranged from 0 to 42 (M = 17.42, SD = 9.70). None of these
measures differed as a function of 5-HTTLPR geno-
type (S vs. LL; P values >.860). Current depressive
symptoms (BDI-II) of TSST participants ranged from
0 to 30 (M = 7.37, SD = 7.20) and did not differ as
a function of 5-HTTLPR genotype (P = .646).Table 1 5-HTTLPR genotype distributions





Note. Genotypes are given according to the triallelic classification.A repeated measures ANOVA showed a significant
cortisol increase to the TSST as shown in Figure 2
(F2.69, 70 = 61.41, P < .001, partial η
2 = .47). 5-HTTLPR
genotype was not associated with significant differences in
the overall cortisol response (P = .758) or in baseline corti-
sol levels (P = .900).
SLC6A4 and NR3C1 expression at baseline as a function of
5-HTTLPR genotype and early life stress
The first question we addressed was whether individuals
differed in levels of serotonin transporter gene (SLC6A4)
or glucocorticoid receptor gene (NR3C1) expression, as a
function of either 5-HTTLPR genotype or early life stress,
prior to any social stress exposure at baseline. We found
no significant differences across any of our measures.
There were no significant differences in baseline
SLC6A4 expression as a function of 5-HTTLPR geno-
type (t(66) = −.79, P = .430; Additional file 2: Figure S1,
panel A). There was also no significant correlation be-
tween baseline SLC6A4 expression and ELS for the sam-
ple as a whole or as a function of 5-HTTLPR genotype
(all r coefficients < .1, P values ≥ .539). The absence of
any ELS effects was also noted when we converted mea-
sures of ELS from a continuous to a categorical variable:
either by taking the median split of CTQ total scores
(F3, 63 = .86, P = .358) or applying higher cut-off values
used in prior studies to divide participants into ‘no-ELS’
or ‘ELS’ groups, F3, 63 = .69, P = .410 [similar to 16; de-
tailed in Additional file 1]. There were also no effect of
5-HTTLPR and ELS interaction for both median split ELS
scores (F3, 63 = .08, P = .772) or higher cut-off ELS scores
(F3, 63 = .01, P = .910) on SLC6A4 baseline expression.
There were no significant differences in baseline
NR3C1 expression as a function of 5-HTTLPR genotypeFigure 2 Cortisol response to the TSST. Cortisol levels (mean ± SE of
mean) at different time points after the TSST.
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panel C). There was also no significant correlation
between baseline NR3C1 expression and ELS for the
sample as a whole or as a function of 5-HTTLPR
genotype (all r coefficients < .1, P values ≥ .454). Similar
results were obtained when utilizing categorical ELS
values and investigating their interaction with 5-HTTLPR
genotype (all P values ≥ .307).
SLC6A4 and NR3C1 expression in response to the TSST as
a function of 5-HTTLPR genotype and early life stress
The next question we addressed was whether individuals
differed in levels of serotonin transporter gene (SLC6A4)
or glucocorticoid receptor gene (NR3C1) expression, as
a function of either 5-HTTLPR genotype or early life
stress, in response to the TSST. We found differential
effects for SLC6A4 but not NR3C1.
In response to the TSST, we found that LL individuals
responded with increased SLC6A4 mRNA expression to
the TSST whereas S-group individuals’ expression values
remained unchanged; LL individuals had significantly
higher SLC6A4 expression in response to the TSST than
did S-group individuals (t(66) = 3.71, P < .001) (Additional
file 2: Figure S1, panel B).
We also wanted to examine whether SLC6A4 mRNA
expression varied as a function of an interaction between
5-HTTLPR genotype and ELS. Although a formal inter-
action between 5-HTTLPR genotype and ELS was not sig-
nificant (F3, 63 = .91, P = .343), we conducted exploratory
analyses for each genotype separately, which showed that
SLC6A4 expression was inversely correlated with gene ex-
pression for S-group individuals (r (41) = −.31, P = .042)
but not for LL individuals (r (23) = −.01, P = .967). Similar
results were obtained when ELS was categorized as
no-ELS vs. ELS (F3, 63 = 5.83, P = .001), such that LL indi-
viduals with ELS had the highest SLC6A4 expression
change, followed by LL with no-ELS, S carriers with no-
ELS and S carriers with ELS. The results remained un-
changed when a biallelic classification scheme was used.
NR3C1 expression in response to the TSST did not
differ as a function of 5-HTTLPR genotype (t(66) = −1.46,
P = .149; Additional file 2: Figure S1, panel D). NR3C1 ex-
pression in response to the TSST also did not differ as a
function of ELS for the entire sample, nor for any of the
subsamples as a function of 5-HTTLPR genotype (all r co-
efficients < .2, P values ≥ .237).
Global DNA and SLC6A4 methylation
Global methylation levels, as measured by LINE-1 methyla-
tion, ranged from 71% to 80% (M = 74.77, SD = 2.38).
There was a negative correlation between age and LINE-1
methylation as expected [54]; r(103) = −.25, P = .011.
There were no differences in LINE-1 methylation as a
function of 5-HTTLPR genotype (P = .699).SLC6A4 CpG island average methylation ranged from
7% to 14% (M = 8.85, SD = 1.67), increasing from the 5′
to the 3′ end; intercorrelations between CpG Units were
higher in the 5′ end than the 3′ end as previously re-
ported [40].
Average SLC6A4 methylation correlated positively with
age (r(103) = .33, P = .001), consistent with the literature
suggesting increases in promoter methylation by age
[55]. Controlling for age, SLC6A4 average methylation
was also correlated with LINE-1 methylation (r(102) = .52,
P < .001).
Age was positively correlated with F2 (rs (103) = .34,
P < .001) and F3 (rs (103) = .40, P < .001) but not with
F1 methylation (rs (103) = −.02, P = .867). Controlling
for age, LINE-1 methylation was positively correlated
with F1 (r (102) = .60, P < .001) and F2 (r (102) = .33,
P = .001) methylation but negatively with F3 methylation
(r (102) = −.24, P = .014).
Early life stress: association with global DNA and SLC6A4
methylation
In light of the previously discussed literature, we next
addressed the question whether ELS is associated with
either global DNA or SLC6A4 methylation. There
was no main effect and only a trend for a significant
interaction between ELS and 5-HTTLPR (F3, 67 = 3.74,
p = .056). An exploratory analysis for each genotype
showed that ELS correlated positively with LINE-1
methylation only in LL participants (r (32) = .45, P = .008),
controlling for age. However, this correlation became
non-significant once we controlled for chronic stress
(r (31) = .27, P = .136).
There was no significant correlation between ELS and
average SLC6A4 methylation (r (103) = .09, P = .380),
and results remained unchanged when controlling for
age and LINE-1 methylation. There was also no correl-
ation between ELS and any of the three SLC6A4
methylation factors, controlling for age and LINE-1
methylation (r coefficients < .1, P values ≥ .090). How-
ever, when 5-HTTLPR genotype was taken into account
(again controlling for age and LINE-1 methylation),
there was a significant interaction between 5-HTTLPR
and ELS on F3 methylation (F5, 99 = 7.98, P = .006): ELS
and F3 methylation correlated positively in S-group par-
ticipants (r (67) = .30, P = .015) but not for LL partici-
pants (r (31) = −.28, P = .118). There were no significant
correlations between ELS and F1 or F2 methylation by
5-HTTLPR genotype (Additional file 1: Table S3).
SLC6A4 methylation: association with SLC6A4 and NR3C1
expression and with cortisol release
Given that DNA methylation can regulate gene expression,
we next addressed the question whether SLC6A4 methyla-
tion was associated with differential gene expression of
Table 2 Correlations between SLC6A4 methylation and NR3C1 expression
NR3C1 expression F1 methylation F2 methylation F3 methylation Average methylation
S LL S LL S LL S LL
Baseline .21 .35 .14 .34 −.05 −.12 .09 .16
Response .31* .20 −.03 .06 .14 −.37 .34* −.02
Note. *P < .05. Significant correlations are shown in italics.
Table 3 Partial correlations between SLC6A4 methylation,
chronic stress, and recent depressive symptoms
SLC6A4 methylation
Average F1 F2 F3
All
Recent depressive symptoms .22 .30* .08 −.17
Chronic stress .05 .20* −.04 −.16
S group
Recent depressive symptoms .28 .41** .08 −.16
Chronic stress .20 .41** .01 −.25
LL
Recent depressive symptoms −.02 .14 −.11 −.23
Chronic stress −.16 −.11 .04 −.10
Note. Partial correlations controlling for age and LINE-1 methylation. *P < .05;
**P < .01. Significant correlations are shown in italics.
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ation between SLC6A4 methylation and SLC6A4 expres-
sion overall, for any of the three factors, or as a function of
5-HTTLPR genotype (r coefficients < .2, P values ≥ .203).
There was also no significant correlation between
SLC6A4 methylation and NR3C1 expression overall
(r (68) = .21, P = .082), nor a significant interaction
(F3, 66 = 2.21, P = .142). Exploratory analyses showed a
significant correlation between overall SLC6A4 methyla-
tion and NR3C1 expression for S-group participants only
(r (42) = .34, P = .023). In particular, there was also a cor-
relation between F1 methylation and NR3C1 expression
in S-group participants only, (r (42) = .31, P = .040). Nei-
ther F2 nor F3 methylation were correlated with NR3C1
expression for any of the genotype groups (Table 2).
To further assess the functional significance of these
observations, we conducted additional correlational ana-
lyses with participants’ cortisol responses. There was no
significant correlation between NR3C1 expression and
cortisol response in any of the genotype groups; nor was
there a significant correlation between SLC6A4 F1
methylation and cortisol response in any of the genotype
groups. Only when SLC6A4 F1 methylation results were
further subdivided into tertiles did some differential ef-
fects emerge genotype (Additional file 3: Figure S2).
We also addressed the functional significance of
SLC6A4 methylation in regard to cortisol release in
response to the TSST. There were no significant correla-
tions between cortisol release and SLC6A4 methylation
(overall or for F1 to F3) for the sample overall or as a
function of 5-HTTLPR genotype (all r coefficients < .2,
P > .110).
Chronic stress, recent depressive symptoms: association
with global DNA and SLC6A4 methylation
As discussed in the introduction, a meta-analysis of GxE
interactions differentiated between early life stress and
other stressors. Having examined ELS in the previous
sections, we now turned to the association of chronic
stress and recent depressive symptoms with global DNA
and SLC6A4 methylation.
Chronic stress (controlling for age) correlated signifi-
cantly with global DNA methylation, as measured by
LINE-1 methylation, for the overall sample (r (102) = .23,
P = .019). This correlation was driven by LL participants
(r (32) = .44, P = .010) but not by S-group carriers(r (67) = .15, P = .219). This effect remained unchanged
when controlling for ELS, as well. Recent depressive
symptoms did not correlate significantly with LINE-1
methylation for the overall sample (r (68) = .19, P = .111),
nor as a function of 5-HTTLPR genotype (S carriers:
r (42) = .19, P = .209; LL: r (23) = .22, P = .284).
Chronic stress (controlling for age and LINE-1 methy-
lation) did not correlate significantly with overall
SLC6A4 methylation for the overall sample, nor as a
function of 5-HTTLPR genotype (Table 3). Recent de-
pressive symptoms correlated only marginally with over-
all SLC6A4 methylation (r(67) = .22, P = .064; Table 3).
When we investigated the association of chronic stress
and recent depressive symptoms for each SLC6A4
methylation factor separately, there was a significant
interaction between 5-HTTLPR and chronic stress
(F5, 99 = 4.01, P = .048) but not for recent depressive
symptoms (F5, 66 = 1.17, P = .283) on F1 methylation. A
follow-up analysis by genotype found that the correlations
were driven by the S group (r = .41, P < .01) but not LL
participants (r = -.16, P > .519; Table 3). The results
remained unchanged when controlling for ELS as well.
A summary of the current study findings is given in
Table 4.
Discussion
This study aimed to address mechanisms of GxE interac-
tions shaping individual differences in social stress
Table 4 Summary of the major study findings
DNA methylation Gene expression change in response to the TSST
SLC6A4 expression: LL > S-group
Early life stress ↑ LINE-1 methylation: S-group ↔ LL ↑ SLC6A4 expression: S-group ↓ LL ↔
F3 methylation: S-group ↑ LL ↔
Chronic stress ↑ LINE-1 methylation: S-group ↔ LL ↑ F1 methylation correl w/ NR3C1 expression: S-group ↑ LL ↔
F1 methylation: S-group ↑ LL ↔
Note. Arrows pointing up or down indicate significantly increased or decreased methylation/expression, respectively. Sideway arrows indicate no significant change.
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stress paradigm, we investigated the relationship be-
tween SLEs and genetic and epigenetic variations, as
well as their downstream effects on gene expression and
HPA activity. We focused in particular on SLC6A4,
which has been shown to moderate the effects of stress-
ful life events and HPA reactivity.
We began our analyses with an in vivo blood-based
assessment of serotonin transporter (SLC6A4) or gluco-
corticoid receptor (NR3C1) mRNA expression at base-
line, as a function of either 5-HTTLPR genotype or ELS.
We found no significant differential gene expression at
baseline as a function of genotype or life stress, nor an
interaction between these two variables. One other
group, focusing on SLC6A4, conducted a similar study
and did report lower levels of SLC6A4 mRNA expression
as a function of 5-HTTLPR genotype and ELS, as well
as an additive effect of these two variables [16]. Our
sample was about 20% smaller, and it is therefore
possible that we lacked statistical power to detect a
difference.
When we turned our attention to the dynamic
regulation of SLC6A4 expression following exposure
to the TSST, we found evidence for a regulatory role
of 5-HTTLPR genotype: LL homozygotes showed a
1.5-fold increase in gene expression following the
stressor, whereas S-group individuals’ expression levels
remained unchanged. This finding is consistent with
Mueller et al.’s study showing increased responsiveness
to the TSST in LL homozygotes (when collapsed across
SLEs), as measured by cortisol activation [24]. This find-
ing is also consistent with Glatz et al.’s study [56] that
reported less expression of the S allele following gluco-
corticoid stimulation. One reason for the difference in
dynamic gene expression as a function of 5-HTTLPR
genotype may be related to structural features in the pro-
moter region of SLC6A4 (as determined by the PROMO
software; [57]), which contains several transcription fac-
tor binding sites (for example, AP-2, GR-α, Sp1) that are
important in the glucocorticoid system [3,56]. Another
reason may be differential affinity for methylation-related
proteins as a function of 5-HTTLPR genotype [58]. To
our knowledge, previous human studies did not considerthe effect of 5-HTTLPR genotype on stress-related
dynamic changes in PBMC SLC6A4 expression. Thus,
replication of this result in larger samples would be
important.
Although change in SLC6A4 expression was not af-
fected as a function of ELS per se, it was affected as a
function of the interaction between ELS and 5-HTTLPR
genotype: ELS further exacerbated the reduced rate of
change in SLC6A4 expression to the TSST in S carriers
but not in LL homozygotes. This result is similar to a set
of rhesus macaque studies, which reported that ELS was
associated with decreased SLC6A4 expression in re-
sponse to a stressor [14,59]. However, these studies did
not report a differential effect of 5-httlpr genotype,
which may reflect lacking statistical power due to the
low number of subjects, particularly of SS genotype. The
life stress effects we observed were specific to ELS, be-
cause we did not find a correlation between recent stress
events and SLC6A4 expression, consistent with another
recent study [16]. Thus, our data suggest a model by
which ELS appears to differentially amplify the genotype
effects on dynamic SLC6A4 expression in S carriers,
which may render them vulnerable for psychopathology
following stress exposure.
ELS may alter gene expression through modifications
in DNA methylation [33]. To address this question, we
considered both global LINE-1 and gene-specific
SLC6A4 methylation. Indeed, ELS (as well as chronic
stress) correlated positively with LINE-1 methylation but
only in LL participants. These results are consistent with
a recent study in LL macaques that also reported an as-
sociation between animals’ stress response and global
and SLC6A4 methylation in individuals who had ex-
perienced ELS [39]. ELS and chronic stress may affect
LINE-1 methylation through a common pathway, because
when we controlled for chronic stress, the correlation be-
tween ELS and LINE-1 methylation became nonsignificant.
Future work conducted with larger samples should repli-
cate this finding and examine possible molecular mecha-
nisms by which chronic stress and ELS may alter LINE-1
methylation.
ELS did not correlate significantly with average
SLC6A4 methylation, nor with methylation of any of the
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ELS may be associated with site-specific SLC6A4 methy-
lation as a function of 5-HTTLPR genotype: ELS corre-
lated positively with F3 (but not with F1 or F2)
methylation but only in S-Group participants. This
finding suggests that not all CpG regions within
SLC6A4 may be equally sensitive to ELS as a func-
tion of 5-HTTLPR genotype. Given our small sample,
this conclusion remains speculative until replicated in
a larger sample.
One way to assess whether methylation of a particular
CpG region is functionally significant is to consider it in
the context of gene expression. Here, we found no
evidence that F3 methylation, as a function of ELS
and 5-HTTLPR genotype, correlated significantly with
SLC6A4 mRNA expression. Indeed, there was no evi-
dence for any relation between SLC6A4 methylation and
SLC6A4 mRNA expression overall, for any of the three
factors, or as a function of 5-HTTLPR genotype. This
observation is consistent with another study that con-
cluded that methylation of SLC6A4 was unlikely to mod-
erate its expression [16].
It is possible, however, that SLC6A4 methylation may
exert an effect through indirect pathways, by regulating
NR3C1 expression [21]. Indeed, we discovered that there
was a significant correlation between overall SLC6A4
(as well as F1) methylation and NR3C1 expression but
only for S-group participants. This association did not,
however, produce a corresponding differential cortisol
response as one might expect [21], casting some doubt
on the functional significance of this association.
In addition to ELS, we also examined the association
of chronic stress and current depressive symptoms with
global and with SLC6A4 methylation (albeit, the exclu-
sion of participants with a history of, or current, depres-
sion restricted the range of observed depressive
symptoms). We found that both chronic stress and re-
cent depressive symptoms were positively correlated
with F1 methylation (a region in the 5′ end of the
SLC6A4 CpG island) in S group but not LL participants.
Importantly, these results remained significant when we
controlled for age, LINE-1 methylation, and ELS. Given
that short allele carriers exposed to life stress are more
likely to show depressive symptoms [6], these findings
are in line with previous studies that associated higher
SLC6A4 methylation with depression [36,40,45]. Our F1
region overlaps with a region examined in a study of
MZ twins that reported a positive association between
BDI scores and methylation [45]. This F1 region also
overlaps with one examined in a study of job burnout in
nurses [60]: when adjusted for working environment
(high vs. low stress), methylation of this region was posi-
tively associated with increased burnout. The study
found no influence of 5-HTTLPR genotype, which mayreflect limited statistical power due to sample size. Taken
together, our results and these other studies suggest
that the region overlapping with F1 of the SLC6A4
CpG island may be particularly plastic and sensitive
to the effects of chronic or recent (as opposed to early)
stressors.
SLC6A4 F1 methylation may exert its effects by regu-
lating gene expression. Although there was no associ-
ation between SLC6A4 F1 methylation and SLC6A4
expression, there was a link with NR3C1 expression.
This link may reflect underlying structural features of
the F1 region, which contains multiple binding sites for
glucocorticoid receptors as determined by the PROMO
software [57]. The link between SLC6A4 F1 methylation
and NR3C1 expression was genotype specific: F1 methy-
lation was positively correlated with NR3C1 expression
in S group but not LL individuals. The functional signifi-
cance of this observation remains tentative because there
was no significant correlation between either SLC6A4 F1
methylation or NR3C1 expression, on the one hand, and
cortisol response to the TSST, on the other. Exploratory
data suggest that level of F1 methylation may be a mod-
erating factor, but our sample was too small to make any
conclusive statements (Additional file 3: Figure S2).
Strengths and limitations
One of the strengths of this study is that our sample was
homogeneous. We limited enrollment to Caucasians to
minimize ethnic stratification. We enrolled only males
to minimize the confounding effects of steroid hormones
on HPA reactivity. We excluded individuals with a previ-
ous diagnosis of psychopathology and related medication
use. These criteria are important considering their con-
founding effects on DNA methylation [46,61], brain
activity, and physiology [62].
The homogeneity of our sample comes at the cost of
limited generalizability, since our data cannot be extrap-
olated to non-Caucasians, women, or individuals with
psychopathology. Furthermore, the exclusion of individ-
uals with diagnosed psychopathology may have limited
the number of study participants with high levels of ELS
(N = 18). Thus, the results of our analyses involving ELS
should be considered preliminary, particularly when this
cohort is further divided by 5-HTTLPR genotype. We
also did not correct for multiple testing due to the ex-
ploratory nature of the study. Therefore, we suggest that
future studies recruit broader and larger samples of the
population (women, minorities) and also recruit spe-
cifically for individuals with high levels of early life
stress history and statistically control for diagnosis of
psychopathology.
The exclusion of patients with psychopathology also
limited the number of participants with large numbers
of ELS events or with specific types of ELS, such as
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this narrow window of ELS, we observed important
changes in DNA methylation, gene expression, and cor-
tisol response. Use of different measures for ELS,
chronic stress, and depressive symptoms allowed us to
investigate their contributions as well as control for their
effects on each other.
The study design was cross-sectional and based in
large part on retrospective self-report, so that some vari-
ables of interest, such as ELS, are difficult to verify ob-
jectively. Furthermore, as is common in human studies
of this kind, our observations are by necessity correl-
ational. Thus, future longitudinal studies in humans, as
well as studies based on animal models and in vitro pro-
cesses, will be crucial to complement these results and
to further develop mechanistic models of GxE interac-
tions observed here.
A strength of this study is that it classified 5-HTTLPR
genotype according to both biallelic and triallelic coding
schemes [4,5,52]. However, due to sample size, we lacked
the power to analyze each genotype group separately.
Future studies with higher sample sizes should investi-
gate these groups separately together with their interac-
tions with early and recent stress measures.
A particularly strong feature of our study was the
focus on dynamic changes in gene expression in re-
sponse to the TSST in a within-subject study design.
However, because blood samples were only analyzed for
changes between baseline and 105 min after the TSST, it
is possible that we did not capture the peak in gene ex-
pression. On the other hand, for a subset of the partici-
pants, we had gene expression data 45 min after the
TSST (unpublished results), which suggested a gradual
increase in the expression of SLC6A4 and NR3C1 from
baseline to 105 min after the TSST. In addition, a study
by Nater et al. [63] reported changes in gene expression
in stress- and immune-related pathways as early as
60 min following the TSST, although another study re-
ported continued gene expression changes up to 24 h
following stress exposure [64]. Taken together, future
studies should measure the expression of candidate
genes at multiple time points after the stressor.
Finally, this study had two strong features with regard
to its epigenetic analyses: it controlled for global methy-
lation effects [31], and it included the majority of the
CpG Units in the SLC6A4 CpG island. The latter fea-
ture is important, because considering only a part of
CpG sites maybe misleading, as different CpG sites
may vary substantially in terms of their TF binding
sites and infrastructure to attract methylation-related
proteins [61,65].
One important limitation of this study is that our
epigenetic analyses are based on peripheral biomarkers,
that is, PBMCs, rather than brain tissue from regionsinvolved in stress processing. Yet, there is growing evi-
dence that DNA methylation patterns may be similar
across tissues and species [66-68]. This may also apply
to stress-related changes in methylation. For example, in
relation to NR3C1 methylation, the same region associ-
ated with ELS was found to be highly methylated in rat
[28] and human postmortem hippocampus [30], human
leukocytes [32], and cord blood [31]. In addition, there is
also recent evidence suggesting effects of peripheral
DNA methylation of candidate genes such as SLC6A4
and catechol-o-methyl transferase on brain activity
[42,69]. A multi-pronged approach combining a variety
of species in vivo, in vitro, and postmortem will be re-
quired to further elucidate the underlying mechanisms
of stress affecting gene expression.
Future research
In light of the limitations discussed above, future re-
search should be extended to ethnically diverse popula-
tions, to women, and to patient populations in order to
examine the differential impact of stress and 5-HTTLPR
genotype on gene expression, DNA methylation, and
HPA response [24,33,70-72].
Future TSST study designs could be further strength-
ened by including an active control condition. For ex-
ample, Het and colleagues [73] introduced a placebo
version of the TSST, which retained the free speech and
arithmetic aspects of the task but removed its stressful
features of uncontrollability and social evaluation. Inclu-
sion of an active control condition could further define
social stress-related aspects of gene expression and serve
as a control condition against possibly spurious correla-
tions. This would also be beneficial to dissociate gene
expression changes due to diurnal variation and those
induced by stressors like the TSST.
Future work also needs to address causal mechanisms.
For example, studies investigating the impact of ELS on
NR3C1 expression across different species and in differ-
ent tissues (hippocampus to blood) have provided im-
portant insights. This multi-pronged approach would
also allow us to better understand the neuroanatomical
bases of these interactions similar to [74]. In addition,
in vitro studies investigating the effects of TF binding
and methylation at target sites on expression and gluco-
corticoid response would complement these studies.
Indeed, future studies should focus on mechanistic ex-
planations for differential gene expression, by focusing
on the putative role of TF expression and binding
in vitro. In addition, it would be important to investigate
the effect of SLC6A4 in concert with other genes, such
as brain-derived neurotrophic factor (BDNF). Previous
GxE studies suggested combined effects of 5-HTTLPR, a
polymorphism in BDNF, and life stress on HPA activity
and depression such as [75-77], and a recent review
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phisms on the development and chronicity of depression
[78]. The association of ELS and BDNF methylation is
also under investigation [79], making it an ideal gene to
investigate its genetic and epigenetic interactions with
SLC6A4.
Conclusions
We conclude that individuals respond differently to
stress as a function of 5-HTTLPR genotype, both at the
level of SLC6A4 and NR3C1 gene expression and at the
level of gene methylation. Compared to S-group individ-
uals, LL individuals responded with increased SLC6A4
mRNA levels to the TSST and also show increased glo-
bal methylation as a function of ELS and chronic stress.
Compared to LL individuals, S-group individuals showed
reduced SLC6A4 mRNA levels and increased F3 methy-
lation as a function of ELS; as well as increased F1
methylation as a function of chronic stress and recent
depressive symptoms, which correlated positively with
NR3C1 expression. These findings highlight the complex
interplay by which an individual’s genotype and type of
life stressor may affect DNA methylation and gene ex-
pression with relevance to HPA activity, to contribute to
individual differences in disease susceptibility or resilience.
Additional files
Additional file 1: Supplementary information. This file contains more
detailed information on exclusion criteria, ELS categorization details, DNA
methylation, and qPCR protocols.
Additional file 2: Figure S1. SLC6A4 (A-B) and NR3C1 (C-D) gene
expression at baseline and in response to the TSST as a function of
5-HTTLPR genotype. There were no significant differences in gene
expression by 5-HTTLPR genotype, except for SLC6A4 expression in
response to the TSST. LL individuals increased SLC6A4 mRNA expression to
the TSST whereas S-group individuals remained unchanged; LL individuals
had significantly higher SLC6A4 expression in response to the TSST than did
S-group individuals (***P < .001).
Additional file 3: Figure S2. NR3C1 expression and cortisol peak
response as a function of 5-HTTLPR genotype in the top tertile of SLC6A4
F1 methylation. For individuals in the lower two tertiles of F1 methylation,
there was no correlation between NR3C1 expression and cortisol response
for any of the genotype groups (all P values >.05). For individuals in the top
tertile, NR3C1 expression correlated positively with cortisol peak response
for S-group participants (r (18) = .60, P = .006), but not LL participants
(r (9) = −.22, P = .523).
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